Cyclerion Therapeutics(CYCN.US)

Last Updated 19:00:00 ET
longbridge loading

14:55 ETAre OGN, TBRG, CYCN Obtaining Fair Deals for their Shareholders?

prnewswire·
US
OGN
+0.15%
US
TBRG
+0.04%
US
CYCN
+1.17%
prnewswire·
US
OGN
+0.15%
US
TBRG
+0.04%
US
CYCN
+1.17%

15:30 ETAre UNF, NSA, CYCN, ULYX Obtaining Fair Deals for their Shareholders?

prnewswire·
US
NSA
+2.04%
US
ULYX
0.00%
US
UNF
-0.24%
prnewswire·
US
NSA
+2.04%
US
ULYX
0.00%
US
UNF
-0.24%

14:15 ET$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--CYCN, CECO, THR, and CWAN

prnewswire·
US
CYCN
+1.17%
US
CWAN
-0.02%
US
THR
+1.29%
prnewswire·
US
CYCN
+1.17%
US
CWAN
-0.02%
US
THR
+1.29%

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

benzinga_article·
US
PFSA
-0.74%
US
KPRX
+0.40%
US
CUPR
-4.47%
benzinga_article·
US
PFSA
-0.74%
US
KPRX
+0.40%
US
CUPR
-4.47%

12 Health Care Stocks Moving In Monday's Pre-Market Session

benzinga_article·
US
ANVS
-6.96%
US
CYCN
+1.17%
US
XPH
+1.90%
benzinga_article·
US
ANVS
-6.96%
US
CYCN
+1.17%
US
XPH
+1.90%

Pre-market hot trades in US stocks: Oriental Rise pre-market down 15.77%; Cyclerion Therapeutics pre-market down 10.24%

Price Alert·
US
ORIS
-0.47%
US
CYCN
+1.17%
Price Alert·
US
ORIS
-0.47%
US
CYCN
+1.17%

Immunovant eye drug flunks Phase 3 studies; Beam sickle cell data published in NEJM

biopharmadive·
US
PBE
0.00%
US
OCEA
-66.67%
US
XBI
+1.70%
biopharmadive·
US
PBE
0.00%
US
OCEA
-66.67%
US
XBI
+1.70%

14:45 ETSHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Cyclerion Therapeutics, Inc. (NASDAQ: CYCN)

prnewswire·
US
ARKG
+1.32%
US
SBIO
+1.96%
US
CYCN
+1.17%
prnewswire·
US
ARKG
+1.32%
US
SBIO
+1.96%
US
CYCN
+1.17%
© 2026 Longbridge｜Disclaimer